This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Technical Scrutiny: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, And Raptor Pharma Corp.

LONDON, September 19, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, September 18, 2013, the Dow Jones Industrial Average, the S&P 500 and the NASDAQ Composite finished the day 0.95%, 1.22% and 1.01% higher, respectively. Shares in the major drug manufacturer companies ended mostly on a higher note as the broader market posted gains. The major movers included GlaxoSmithKline PLC (NYSE: GSK), Keryx Biopharmaceuticals Inc. (NASDAQ: KERX), AstraZeneca PLC (NYSE: AZN), and Raptor Pharmaceutical Corporation (NASDAQ: RPTP). AAAResearchReports.com has tracked GSK, KERX, AZN, and RPTP. These reports can be seen for free at:

http://www.aaaresearchreports.com/register/  

On Wednesday, GlaxoSmithKline PLC's stock advanced to close at $51.27, up 0.27% from the previous day's closing price of $51.13. The company's shares oscillated between $50.53 and $51.40 during the trading session. A total of 2.41 million shares were traded, which is above the daily average volume of 2.08 million. The company's shares have lost 0.27% in the previous three trading sessions, compared to a gain of 2.22% in the S&P 500 during the same period. Further, GlaxoSmithKline PLC's stock is trading above its 200-day moving average of $48.53. Download free research on GSK by signing up now at:

http://www.AAAResearchReports.com/GSK091913.pdf

Shares in Keryx Biopharmaceuticals Inc. fell sharply on Wednesday, even as the broader market posted significant gains. The company's shares fluctuated between $9.56 and $9.93 before closing the day 1.00% lower at $9.90. A total of 2.94 million shares were traded, which is more than the daily average volume of 1.92 million. Despite Wednesday's pullback, the company's shares have rallied 18.14% in the previous one month and 29.24% in the last three months, outperforming the S&P 500 which has gained 4.21% and 4.46% during the respective periods.  Moreover, Keryx Biopharmaceuticals Inc.'s stock has moved closer to its 52-week high of $10.04 as well as above its 50-day and 200-day moving averages of $8.82 and $6.97, respectively. Register for today's free analysis on KERX at:

http://www.AAAResearchReports.com/KERX091913.pdf

On Wednesday, AstraZeneca PLC's shares rose sharply by 1.58%, tracking gains in the US equity market. The company's shares finished the day at $52.08 after fluctuating between $51.22 and $52.13 during the trading session. A total of 1.36 million shares were traded, which is below the daily average volume of 1.68 million. The company's stock has gained 2.82% in the previous three trading sessions and 4.18% in the last one month, outperforming the S&P 500 which has gained 2.22% and 4.21% during the respective periods. Additionally, AstraZeneca PLC's shares are trading above their 50-day 200-day moving averages of $50.16 and $49.27, respectively. A free report on AZN can be accessed by registering at:

http://www.AAAResearchReports.com/AZN091913.pdf

Shares in Raptor Pharmaceutical Corp. edged higher on Wednesday, extending the gains from the previous trading session. The company's shares finished the day 0.35% higher at $14.35 after fluctuating between $14.04 and $14.42 during the trading session. A total of 0.60 million shares were traded, which is below the daily average volume of 0.72 million. The company's shares have rallied 83.27% in the previous three months and 25.88% in the last one month, outperforming the S&P 500 which has advanced 4.46% and 4.21% during the respective periods. Further, Raptor Pharmaceutical Corp.'s stock is trading close to its 52-week high of $14.90 as well as above its 50-day and 200-day moving averages of $11.80 and $7.57, respectively. Register with AAA Research Reports and download research on RPTP for free at:

http://www.AAAResearchReports.com/RPTP091913.pdf

----

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,954.21 -129.59 -0.76%
S&P 500 1,978.95 -9.03 -0.45%
NASDAQ 4,449.1420 -22.9660 -0.51%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs